This is especially important because the wrong response to side effects can create a downward spiral: nausea leads to under-eating under-eating leads to weakness and poor protein intake poor intake and GI symptoms contribute to dehydration exercise tolerance drops patients lose weight, but not in a healthy or durable way A supervised plan helps interrupt that pattern early
When I started taking a GLP-1 medication in October, I knew it would probably change a few thingsour weekly dinner plan, how my pants fit, my relationship to alcohol (initial research shows low-dose GLP-1 drug patients drink less of it)
Patients should seek immediate medical advice if they experience severe, persistent abdominal pain (which may indicate pancreatitis), right-sided abdominal pain with fever or jaundice (possible gallbladder disease), or any visual changes (particularly if blood glucose is improving rapidly)
Our 2030 estimates contemplate global penetration into the addressable type 2 diabetes and obesity markets of only 8% and 2%, respectively (from about 3% and 0.2% in 2023). Uptake would likely be greater if these drugs could be consumed in oral form rather than injected, adds the report, An oral weight loss agent would likely be well-received in the primary care setting and could alleviate pressure on supply chains
A better way to compare these treatments is by matching the medication strategy to the person
doi: 10.1002/brb3.1505 80 BatistaAFForny-GermanoLClarkeJRLyraESNMBrito-MoreiraJBoehnkeSEet al